LP10
LP10 is a non-azole CYP51 inhibitor with activity against Trypanosoma cruzi infection. Treatment with LP10 blocks the 14α-demethylation step, leading to disruption of the parasite cell membrane and ultimately triggering the death of important clinically relevant amoeba stages[1].
Product Specifications
CAS Number
1025400-45-6
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lp10.html
Smiles
O=C(C(CC1=CNC2=C1C=CC=C2)NC(C3CCC(CC3)C)=O)NC4=CC=NC=C4
Molecular Formula
C24H28N4O2
Molecular Weight
404.50
References & Citations
[1]A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1487194-01 0.02 mg (E-Coli)
Recombinant Mouse Gasdermin-A2 (Gsdma2)
Sign In for Pricing
View Details MBS1487194-02 0.02 mg (Yeast)
Recombinant Mouse Gasdermin-A2 (Gsdma2)
Sign In for Pricing
View Details MBS1487194-03 0.1 mg (E-Coli)
Recombinant Mouse Gasdermin-A2 (Gsdma2)
Sign In for Pricing
View Details MBS1487194-04 0.1 mg (Yeast)
Recombinant Mouse Gasdermin-A2 (Gsdma2)
Sign In for Pricing
View Details MBS1487194-05 0.02 mg (Baculovirus)
Recombinant Mouse Gasdermin-A2 (Gsdma2)
Sign In for Pricing
View Details MBS1487194-06 0.02 mg (Mammalian-Cell)
Recombinant Mouse Gasdermin-A2 (Gsdma2)
Sign In for Pricing
View Details